Share on

Global Cell Analysis Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report - Segmented By Techniques, Product, Application, End-User and Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 8735
Pages: 150
Formats: report pdf report excel report power bi report ppt

Cell Analysis Market Size (2022 to 2027)

According to the recent market analysis, the global Cell Analysis Market size is estimated to reach USD 28.44 billion by 2027, witnessing a healthy growth rate of 8.12% during the forecast period.

Cell Analysis Market

Global Cell Analysis Market Size (2022 to 2027)

Cell analysis ensures to discover quality drugs in very little time than projected. It also studies the behavior of cells in multicellular and unicellular organisms. In the process of gene identification, cell analysis plays a significant role in monitoring the genetic behavior of the organism. From this cell analysis report, one can study the complete processes of a cell, such as the growth and proliferation of a cell.


The cell analysis technique is a boom for pharmaceutical companies as they can develop various drugs at low cost within the projected time period. This is considered a primary factor propelling the global cell analysis market demand.

Increasing incidences of chronic diseases and other health disorders across the world are secondary factors driving the market's growth. People demand personalized medicine to have convenient and private treatment procedures is accelerating the growth of the market. Growing research on cells and the launch of innovative products with the help of the cell analysis process boost the demand of the Global Cell Analysis Market. The increasing geriatric population is also an attribute fuelling the rate of cell analysis market growth.

Growing awareness among individuals in the diagnosis and treatment procedures is leveraging the growth rate of the Global Cell Analysis Market. The increasing scale of biopharmaceutical & biotechnological companies is impacting the growth of the market positively. Rising expenditure on healthcare, especially in urban areas, is creating chances for the market to grow. Growth opportunities for the market lie in the increasing number of research and development institutes to improve the quality of the drugs and lavish the demand of the market. The rise in the demand for imaging techniques also escalates the cell analysis market growth.

The adaptation of flow cytometry in novel research applications like proteomics, marine cell biology, and cytogenetics has boosted the cell analysis market growth rate. Also, the rising incidences of HIV and cancer have created the demand for flow cytometry techniques for efficient diagnostics in hospitals and laboratories. Moreover, the advent of reagents and multiple probes for usage in diagnostics and drug discovery is expected to benefit the cause of cell analysis companies targeting the consumers in research/academic areas and small laboratories.

Further, with the advent of cell analysis applications in the oncology domain, the market is expected to experience an unconventional growth rate in the next few years. Cancer cell analysis involves studying tumor cell biology and the development of cell-based therapies and therapeutics for cancer. Considering these novel applications, investments for research in the field of cancer are on the rise, of which the cell assay-based drug developments have gained high importance and interest, thereby amplifying the growth of demand for cell analysis instruments or technologies.  According to the WCR Fund, global cancer research funding increases at the rate of 10% annually, resulting in a total expenditure of $177 billion on cancer research. Adding to this trend, the UNITED STATES federal government, Cancer Research U.K, and the Australian government, among others, are also investing in cancer research on a large scale. Recent developments in biomarker technology and stem cell analysis are also providing traction during the forecast period.


The dearth of skilled persons in the laboratories to analyze the reports is slightly declining the global cell analysis market.

The cost of installing the equipment to perform the process is a bit expensive, which slightly hampering the growth of the Global Cell Analysis Market. Lack of standardization may also degrade the demand of the market quietly. The entry of new players and increasing competition between them is a challenging factor for the market developers. Strict rules and regulations to approve new products are inhibiting the demand of the market.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Type, Production Technologies, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Bayer HealthCare AG, Bioniche Animal Halth Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health, Inc., Merck & Co. Inc. and Protein Sciences


This research report segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2027.

Cell Analysis Market Analysis - By Techniques:

  • Molecular Approaches
    • PCR
    • Sequencing
    • Microfluidics and Microarrays
    • Cell Isolation and Separation
  • Image-Based Approaches
    • Microscopy
    • Cytometry
    • High Content Screening
    • Spectrophotometry

Based on techniques, the PCR segment had the largest shares in 2018 among all. The image-based approach has been sub-segmented into microscopy, cytometry, high content screening, and spectrophotometers. The cytometry segment held the largest market share in the year 2018 among all the segments.

Cell Analysis Market Analysis - By Product:

  • Consumables
    • Assay Kits
    • Reagents
    • Microplates
    • Cell Culture Consumables
    • Others
  • Instruments
    • Cell Counters
    • Cell Microarrays and Microfluidics
    • Liquid Handling Systems
    • Cytometers
    • High Content Screening Systems
    • Microplate Readers
    • PCR Instruments
    • Sequencing Instruments
    • Spectrophotometers
    • Microscopes
    • Other Instruments
  • Software and Services

Based on product, the Consumables product type is leading with the highest shares of the market. The growing prevalence for the use of appropriate devices in the laboratories to evaluate the best results is likely to outshine the market demand.

Cell Analysis Market Analysis – By Application:

  • By Process of Application
    • Cellular Processes
    • Signal Transduction Pathway
    • Circulating Tumor Cells
    • Single-Cell Analysis
    • Epigenetic Target Analysis
    • Subpopulation Characterization
    • Drug and Candidate Screening
  • By Field of Application
    • Forensics
    • Therapeutics
    • Genomic Analysis
    • Stem Cell Analysis
    • Biomarker Research
    • Cell Imaging
      • Live-Cell Imaging
    • Diagnostics
  • By Therapeutic Area of Applications
    • Cancer Research
    • Genetic Testing
    • Infectious Diseases
    • Immunology
    • Others

Cell Analysis Market Analysis – By End-User:

  • Hospitals
  • Academic & Research Laboratories
  • Diagnostic Laboratories
  • Pharmaceuticals and Biotech Companies
  • Contract Research Organisations
  • Cell Banks
  • Others

Cell Analysis Market Analysis – By Region:

  • North America Cell Analysis Market
  • Europe Cell Analysis Market
  • Asia-Pacific Cell Analysis Market
  • Latin America Cell Analysis Market
  • Middle East & Africa Cell Analysis Market

Regionally, North America is accounted for in leading dominant shares of the global cell analysis market with the rise in the capital income in developed and developing countries. The growing prevalence to have cost-effective drugs is magnifying the growth rate of the North America Cell Analysis market. Also, the rise in the investments in the research institutes by private and public organizations is propelling the market's demand.

The Asia Pacific is positioned second in dominating the shares due to the acceptance of the latest technological advancements and introducing innovative techniques in the diagnostic centers. The rising elderly population is one of the factors spurring the demand of the market. Europe has the fastest growth rate in recent years and is also expected to hit the highest CAGR in the coming years. Increasing support from the government by introducing reimbursement schemes to provide better treatment processes for the common people broadens the demand of the European Cell Analysis market. The Middle East and Africa are deemed to have inclined growth rates in foreseen years.


Some of the notable companies leading the global cell analysis market profiled in this report are

  1. Becton, Dickinson, and Company (United States)
  2. Thermo Fisher Scientific, Inc. (UNITED STATES)
  3. Merck KGaA (Germany)
  4. Danaher Corporation (UNITED STATES)
  5. GE Corporation (United Kingdom)
  6. Olympus Corporation (Japan)
  7. Agilent Technologies, Inc. (UNITED STATES)
  8. PerkinElmer, Inc. (UNITED STATES)
  9. Promega Corporation (UNITED STATES)
  10. Tecan Group Ltd. (Switzerland)

Recent Market Developments:

  • Product Launch - In August 2019, a multimode real-time cell analyzer (RTCA) was launched by Agilent Technologies. This is the first kind of product introduced with the combination of non-invasive biosensors and live-cell imaging. This company is has started research mainly on immuno-oncology and immunotherapy applications.
  • Product Launch - On June 24, 2019, Sony launched the ID7000™ flagship spectral cell analyzer, which is capable of streamlining multicolor cell analysis for more than 44 colors. The launch of this product will empower deep insights into cell information and also boost up the growth in the market. 
  • Product Launch - In April 2019, a product for BioPharma named Vi-CELL BLE cell viability analyzer was introduced by Beckman Coulter. This product has high demand in the coming years as this shows great viability in monitoring the cell in laboratories.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample